Showing results (101-110 of 126) with videos related to
Sort By:
Pageof 13
Anticancer Research|May 31, 2015
Evaluation of IL-2, IL-6, IL-8 and IL-10 in Malignant Melanoma DiagnosticsRadek Kucera, Ondrej Topolcan, Inka Treskova, et al.Anticancer Research|May 29, 2017
Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell CarcinomasDavid Kalfert, Marie Ludvikova, Ondrej Topolcan, et al.International Journal of Cancer|August 12, 2018
Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomesUrsula Altanerova, Jana Jakubechova, Katarina Benejova, et al.Cancer Genomics & Proteomics|August 30, 2020
Association of miR-125b, miR-17 and let-7c Dysregulations With Response to Anti-epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With Metastatic Colorectal CancerOndrej Fiala, Ondrej Sorejs, Petr Hosek, et al.Anticancer Research|January 29, 2011
Predictive value of serum biomarkers in patients after portal vein embolization (PVE): a pilot studyVladislav Treska, Ondrej Topolcan, Jindra Vrzalova, et al.Anticancer Research|April 13, 2016
Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer DiagnosticsRadek Kucera, David Smid, Ondrej Topolcan, et al.Anticancer Research|September 16, 2016
Prognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate CancerVlastimil Kulda, Ondrej Topolcan, Radek Kucera, et al.In Vivo (Athens, Greece)|June 27, 2024
Prognostic Value of Tumor Tissue Up-regulated microRNAs in Clear Cell Renal Cell Carcinoma (ccRCC)Martin Pesta, Ivan Travnicek, Vlastimil Kulda, et al.Anticancer Research|October 2, 2019
The Predictive Role of Primary Tumour Sidedness in Metastatic Colorectal Cancer Treated With Targeted AgentsOndrej Fiala, Pavel Ostasov, Petr Hosek, et al.Anticancer Research|October 1, 2021
The Role of Serum Tumor Markers in Follow-up After Surgical Treatment of Malignant Lung TumorsJosef Vodicka, Martin Skala, Jakub Sebek, et al.Pageof 13